Austin Health

Title
Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation.
Publication Date
2021
Author(s)
Ronco, Claudio
Bagshaw, Sean M
Bellomo, Rinaldo
Clark, William R
Husain-Syed, Faeq
Kellum, John A
Ricci, Zaccaria
Rimmelé, Thomas
Reis, Thiago
Ostermann, Marlies
Subject
Continuous renal replacement therapies
Cytokine removal
Extracorporeal organ support
Hemoadsorption
Hemoperfusion
COVID-19
Type of document
Journal Article
OrcId
0000-0002-1650-8939
DOI
10.1159/000508125
Abstract
Critically ill COVID-19 patients are generally admitted to the ICU for respiratory insufficiency which can evolve into a multiple-organ dysfunction syndrome requiring extracorporeal organ support. Ongoing advances in technology and science and progress in information technology support the development of integrated multi-organ support platforms for personalized treatment according to the changing needs of the patient. Based on pathophysiological derangements observed in COVID-19 patients, a rationale emerges for sequential extracorporeal therapies designed to remove inflammatory mediators and support different organ systems. In the absence of vaccines or direct therapy for COVID-19, extracorporeal therapies could represent an option to prevent organ failure and improve survival. The enormous demand in care for COVID-19 patients requires an immediate response from the scientific community. Thus, a detailed review of the available technology is provided by experts followed by a series of recommendation based on current experience and opinions, while waiting for generation of robust evidence from trials.
Link
Citation
Blood Purification 2021; 50(1): 17-27
Jornal Title
Blood Purification

Files:

NameSizeformatDescriptionLink